SSY GROUP(02005): Propranolol hydrochloride has been approved by the Chinese drug regulatory authority as a raw material for use in marketed formulations.

12:33 13/02/2026

Sisai Pharmaceutical Group (02005) announced that its metoprolol hydrochloride has been approved by the China National Medical Products Administration for registration as an active pharmaceutical ingredient in marketed formulations.

SSY GROUP (02005) announced that its metoprolol succinate hydrochloride has been approved and registered by the China National Medical Products Administration as an active pharmaceutical ingredient for use in marketed formulations. Metoprolol succinate hydrochloride is mainly used for (i) secondary prevention to reduce mortality after myocardial infarction; (ii) hypertension; (iii) effort-induced angina; and (iv) controlling supraventricular tachycardia and ventricular arrhythmias.

Guolian Minsheng Securities: The deposit ratio of the insurance industry has significantly increased, while the proportion of equity assets has marginally decreased.

HK Stock Market Move | The stocks of domestic insurance companies collectively decline, with China Life Insurance (02628) falling by more than 4%. The investment performance is impacted by the fluctuation of the capital market in the fourth quarter.

EB SECURITIES: Gold prices are expected to remain at the high level and may trend upwards, temporarily stabilizing around the 50-day moving average level.

Guolian Minsheng Securities: The deposit ratio of the insurance industry has significantly increased, while the proportion of equity assets has marginally decreased.

EB SECURITIES: Gold prices are expected to remain at the high level and may trend upwards, temporarily stabilizing around the 50-day moving average level.